[Featured Stocks] SK Discovery and SK Chemicals Hit Upper Limit on SK Bioscience Optimism
[Asia Economy Reporter Minwoo Lee] SK Discovery and SK Chemicals stocks are on the rise. This appears to reflect expectations for contract manufacturing of the novel coronavirus disease (COVID-19) vaccine by their subsidiary SK Bioscience.
As of 2:28 PM on the 10th, SK Discovery's stock price rose to the maximum price limit (29.98%) compared to the previous session, reaching 67,200 KRW. SK Discovery preferred shares also traded at 235,000 KRW, up 25% from the previous session. At the same time, SK Chemicals showed strength, reaching 414,500 KRW, up 22.27% from the previous session.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "To Get Revenge on Ex-Girlfriend" US McDonald's Manager Spits on French Fries
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
The optimism is believed to be driven by expectations for COVID-19 vaccine development by affiliate SK Bioscience. SK Bioscience is a subsidiary in which SK Chemicals holds a 98% stake. SK Discovery holds a 33% stake in SK Chemicals.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
